Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Burden of New-Onset A-Fib Considerable After TAVI, AVR

drugsJune 06, 2019

Tag: TAVI , AVR , A-Fib , fibrillation

PharmaSources Customer Service